Chondroitin sulfate (Cat No.:I020675) is an acidic mucopolysaccharide extracted and purified from animal cartilage tissue. It is mainly used for coronary artery atherosclerotic disease, elevated lipids and cholesterol, atherosclerosis, angina pectoris, myocardial ischemia and myocardial infarction in patients with coronary heart disease.
| Catalog Number | I020675 |
| CAS Number | 9007-28-7 |
| Molecular Formula | (C₁₄H₂₁NO₁₄S)n |
| Purity | ≥95% |
| Reference | [1]. Mikami T, et al. Biosynthesis and function of chondroitin sulfate. Biochim Biophys Acta. 2013 Oct;1830(10):4719-33.<br>[2]. Martel-Pelletier J, et al.Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. Molecules. 2015 Mar 6;20(3):4277-89.<br>[3]. Monfort J, et al. Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues. Ann Rheum Dis. 2008 Jun;67(6):735-40.<br>[4]. Campo GM, et al. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem. 2009 Jan 1;106(1):83-92.<br>[5]. Henrotin Y, et al. Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinicalrecommendations. Ther Adv Musculoskelet Dis. 2010 Dec;2(6):335-48. |
